KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Dividends Paid - Common (2016 - 2025)

AbbVie (ABBV) has disclosed Dividends Paid - Common for 13 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, Dividends Paid - Common rose 5.78% to $2.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $11.7 billion, a 5.73% increase, with the full-year FY2025 number at $11.7 billion, up 5.73% from a year prior.
  • Dividends Paid - Common was $2.9 billion for Q4 2025 at AbbVie, roughly flat from $2.9 billion in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $2.9 billion in Q1 2025 to a low of $2.3 billion in Q2 2021.
  • A 5-year average of $2.6 billion and a median of $2.6 billion in 2023 define the central range for Dividends Paid - Common.
  • Peak YoY movement for Dividends Paid - Common: surged 31.85% in 2021, then rose 4.17% in 2024.
  • AbbVie's Dividends Paid - Common stood at $2.3 billion in 2021, then rose by 8.3% to $2.5 billion in 2022, then rose by 4.79% to $2.6 billion in 2023, then grew by 4.8% to $2.8 billion in 2024, then increased by 5.78% to $2.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Dividends Paid - Common are $2.9 billion (Q4 2025), $2.9 billion (Q3 2025), and $2.9 billion (Q2 2025).